EUCTR2005-003000-11-IT进行中（未招募）不适用
An open-label follow-up trial of the efficacy and safety of chronic administration of the fixed dose combination of telmisartan 80 mg hydrochlorothiazide 25 mg tablets alone or in combination with other antihypertensive medications in patients with hypertension.
BOEHRINGER ING.0 个研究点目标入组 480 人开始时间: 2007年1月18日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 480
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
An open-label follow-up trial of the efficacy and safety of chronic administration of the fixed dose combination of telmisartan 80 mg + hydrochlorothiazide 25 mg tablets alone or in combination with other antihypertensive medications in patients with hypertension.EUCTR2005-003000-11-DKBoehringer Ingelheim Ireland Ltd.480
进行中（未招募）
不适用
An open-label follow-up trial of the efficacy and safety of chronic administration of the fixed dose combination of telmisartan 80 mg + hydrochlorothiazide 25 mg tablets alone or in combination with other antihypertensive medications in patients with hypertension.essential hypertensionEUCTR2005-003000-11-DEBoehringer Ingelheim Pharma GmbH & Co.KG480
进行中（未招募）
不适用
An open-label follow-up trial of the efficacy and safety of chronic administration of the combination of telmisartan 40mg + amlodipine 10mg or the combination of telmisartan 80mg + amlodipine 10mg tablets alone or in combination with other antihypertensive medications in patients with hypertensioessential hypertensionMedDRA version: 9.1Level: LLTClassification code 10015488Term: Essential hypertensionEUCTR2007-002422-29-ATBoehringer Ingelheim Austria GmbH687
进行中（未招募）
1 期
An open-label follow-up trial of the efficacy and safety of chronic administration of the fixed dose combination of telmisartan 80 mg + hydrochlorothiazide 25 mg tablets alone or in combination with other antihypertensive medications in patients with hypertension.EUCTR2005-003000-11-FIBoehringer Ingelheim Finland Ky480
进行中（未招募）
不适用
An open-label follow-up trial of the efficacy and safety of chronic administration of the combination of telmisartan 40mg + amlodipine 10mg or the combination of telmisartan 80mg + amlodipine 10mg tablets alone or in combination with other antihypertensive medications in patients with hypertensioessential hypertensionMedDRA version: 9.1Level: LLTClassification code 10015488Term: Essential hypertensionEUCTR2007-002422-29-CZBoehringer Ingelheim687